Santhera Pharmaceuticals Holding AG
SANN
Rank in Stocks
#16104
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company,... Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia. The company’s lead pipeline candidate includes Vamorolone, which is developed for the treatments of Duchenne muscular dystrophy. Its clinical stage pipeline also comprises Lonodelestat for the treatment of cystic fibrosis and other neutrophilic pulmonary diseases. Santhera Pharmaceuticals Holding AG was founded in 2004 and is based in Pratteln, Switzerland.
Share Price
$19.25
Last synced: 2026-10-20
Market Cap
$294.54M
Change (1 day)
2.64%
Change (1 year)
50.03%
Country
CH
Trade Santhera Pharmaceuticals Holding AG (SANN)
Category
Healthcare
Stock split history for Santhera Pharmaceuticals Holding AG (SANN)
Santhera Pharmaceuticals Holding AG stock (symbol: SANN) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 21, 2026.
One SANN share bought prior to Oct 21, 2026 would equal to 0 SANN shares today.
The most recent stock split occurred on Oct 21, 2026.
One SANN share bought prior to Oct 21, 2026 would equal to 0 SANN shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
